rs200761047
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001171613.2(PREPL):c.40C>T(p.Gln14*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,612,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001171613.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hypotonia-cystinuria syndromeInheritance: AR Classification: STRONG Submitted by: G2P
- myasthenic syndrome, congenital, 22Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151946Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000120 AC: 30AN: 250882 AF XY: 0.000140 show subpopulations
GnomAD4 exome AF: 0.000123 AC: 180AN: 1460414Hom.: 0 Cov.: 31 AF XY: 0.000136 AC XY: 99AN XY: 726570 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151946Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74176 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Myasthenic syndrome, congenital, 22 Pathogenic:3
- -
This sequence change creates a premature translational stop signal (p.Gln103*) in the PREPL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PREPL are known to be pathogenic (PMID: 24610330, 28726805, 29913539). This variant is present in population databases (rs200761047, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PREPL-related conditions. ClinVar contains an entry for this variant (Variation ID: 478315). For these reasons, this variant has been classified as Pathogenic. -
Variant summary: PREPL c.307C>T (p.Gln103X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 0.00012 in 250882 control chromosomes. To our knowledge, no occurrence of c.307C>T in individuals affected with Myasthenic Syndrome, Congenital, 22 and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
PREPL-related disorder Pathogenic:1
The PREPL c.307C>T variant is predicted to result in premature protein termination (p.Gln103*). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.023% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-44573442-G-A). Nonsense variants in PREPL are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at